Raymond James Financial, Inc. · RJF · FY2026 Q2 · Calendar Q2 2026

Raymond James posts record Q2 revenue of $3.86B, EPS beats; securities loans up 31%

Raymond James' record Q2 FY2026 results — driven by adviser recruiting, fee-based asset inflows, securities-based lending growth and a rebounding capital-markets pipeline — support a constructively held view on the shares. Continued net-new-asset generation and steady capital return (buybacks plus acquisitions) underpin durable earnings, while declining pretax yields from rate cuts and a rising compensation ratio are the main near-term margin offsets. Consensus price target of $177.33 versus the $159.87 current price implies modest upside; the stock traded roughly in line with the benchmark around the report.

Reported After market closeNYSEFinancial Services $30.50B market cap
100quality score

Earnings scorecard

Reported versus consensus
Reported EPS $2.83 Consensus $2.76
EPS surprise +2.5% Reported versus consensus
Reported revenue $3.86B Consensus $3.85B
Revenue surprise +0.4% Reported versus consensus

Market reaction

event-close to next-session close
Stock move -0.7% Event window
SPY move -0.4% Same window
Abnormal move -0.3% Stock minus SPY
Volume 2.3× Versus trailing sessions
Subsequent drift -1.9% Up to 20 sessions
RJFSPY benchmark

Ask FN2 about RJF FY2026 Q2

Transcript, numbers and history already loaded

Free account. Your question opens in FN2 with this report's transcript and numbers attached.

Transcript intelligence

What changed

Q2 FY2026 delivered record revenue of $3.86B (+13% YoY) and record pretax income (+10% YoY). EPS of $2.83 topped the $2.76 estimate by ~2.5%. Adviser recruiting produced 7% annualized net new assets in the first half, securities-based loans rose 31% YoY (bank loans $54.8B), technology/AI spend exceeded $1.1B, the GreensLedge acquisition closed, and Clark Capital's close is pending. Guidance was maintained with a confident tone; the shares' move around the print was minimal versus the market.

Guidance delta

maintained

Key takeaways

  • Record Q2 revenue of $3.86B, up 13% YoY, and record pretax income up 10% YoY
  • EPS of $2.83 beat the $2.76 Street estimate, a ~2.5% surprise
  • Adviser recruiting delivered 7% annualized net new assets in the first half
  • Securities-based loans grew 31% YoY, lifting total bank loans to $54.8B
  • Technology and AI spend of >$1.1B underpins efficiency; GreensLedge closed and Clark Capital pending

Management priorities

  • Expand the proprietary AI operations agent to more advisers and explore agentic AI
  • Finalize and integrate the Clark Capital acquisition
  • Maintain or increase technology spend to enhance adviser tools
  • Continue the share repurchase program and broader capital return
  • Grow the securities-based lending franchise and fee-based asset base

Follow RJF with an agent that reads every filing, transcript, and price print. Free to start.

Try FN2 free

Earnings History

Estimate Beat Miss Match
RJF EPS earnings history estimate and actual scatter chart 9 reported fiscal quarters and 4 future estimate-only quarters. Q2 '24 estimate $2.31 Q2 '24 actual $2.31, match Q3 '24 estimate $2.32 Q3 '24 actual $2.39, beat Q4 '24 estimate $2.41 Q4 '24 actual $2.95, beat Q3 '25 estimate $2.37 Q3 '25 actual $2.18, miss Q4 '25 estimate $2.83 Q4 '25 actual $3.11, beat Q1 '26 estimate $2.83 Q1 '26 actual $2.86, beat Q2 '26 estimate $2.76 Q2 '26 actual $2.83, beat Q3 '26 estimate $2.93 Q3 '26 actual $3.14, beat Q4 '26 estimate $3.36 Q1 '27 estimate $3.34 Q2 '27 estimate $3.48 Q3 '27 estimate $3.63
Show 1 more >

Analyst Consensus ?

ConsensusBuy26 ratings
Bullish1246.2%
Neutral1453.8%
Bearish00.0%

Analyst 52W Price Targets

$159.87Current
$123Low
$159.71Average
$205High

Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Sep 25, 2026. Not an FN2 forecast.

Firm-level rating actions

FMP grade actions identify the grading firm, not a named analyst.

FirmRatingPrior ratingActionDate
TD Cowen Hold HoldMaintainSep 1, 2026
Argus Research Buy BuyMaintainJul 30, 2026
UBS Neutral NeutralMaintainJul 27, 2026
JP Morgan Neutral NeutralMaintainJul 23, 2026
Citizens Market Outperform Market OutperformMaintainJul 23, 2026
BMO Capital Market Perform Market PerformMaintainJul 23, 2026
Barclays Overweight OverweightMaintainJul 23, 2026
Morgan Stanley Equal Weight Equal WeightMaintainJul 10, 2026
Jefferies Hold HoldMaintainApr 6, 2026
B of A Securities Neutral NeutralMaintainDec 10, 2025
Keefe, Bruyette & Woods Market Perform Market PerformMaintainOct 23, 2025
JMP Securities Market Outperform Market OutperformMaintainOct 23, 2025
Citigroup Neutral NeutralMaintainSep 22, 2025
Wells Fargo Equal Weight Equal WeightMaintainJul 11, 2025
Goldman Sachs Buy BuyMaintainApr 3, 2025
Wolfe Research Peer Perform OutperformDowngradeJul 8, 2024
Credit Suisse Neutral NeutralMaintainApr 27, 2023
Seaport Global Buy NeutralUpgradeJan 28, 2022
Compass Point Neutral BuyDowngradeMay 1, 2020
Buckingham Research Buy BuyMaintainOct 26, 2018
Buckingham Buy BuyMaintainOct 26, 2018
Keefe Bruyette & Woods Outperform Market PerformUpgradeFeb 27, 2018
Nomura Buy BuyMaintainJul 13, 2017
Macquarie Neutral NeutralMaintainJan 22, 2016
Susquehanna Positive PositiveMaintainJul 15, 2015
S&P Capital IQ Strong Buy BuyUpgradeJul 9, 2012
Show less

Named analyst price targets

Upside is calculated against the persisted current price $159.87. FMP does not supply a rating on these named-analyst rows.

FirmAnalyst52W targetPrice when postedUpsideDate
Raymond JamesAnalyst unavailable$160$178.17 +0.1%Sep 1, 2026
Truist FinancialDavid Smith$188$178.17 +17.6%Sep 1, 2026
UBSAnalyst unavailable$184$172.75 +15.1%Jul 27, 2026
Raymond JamesMichael Cho$179$164.91 +12.0%Jul 23, 2026
Raymond JamesBrennan Hawken$175$165.16 +9.5%Jul 23, 2026
Raymond JamesDevin Ryan$205$168.01 +28.2%Jul 23, 2026
Raymond JamesAnalyst unavailable$174$169.45 +8.8%Jul 10, 2026
Raymond JamesAnalyst unavailable$192$169.9 +20.1%Jul 9, 2026
Raymond JamesAnalyst unavailable$200$165.35 +25.1%Jul 9, 2026
UBSMichael Brown$175$166.58 +9.5%Jul 8, 2026
Raymond JamesAnalyst unavailable$155$143.22 -3.0%May 28, 2026
UBSAnalyst unavailable$166$156.16 +3.8%Apr 23, 2026
Raymond JamesAnalyst unavailable$172$155.91 +7.6%Apr 23, 2026
Raymond JamesMichael Cyprys$171$145.35 +7.0%Apr 10, 2026
Raymond JamesAnalyst unavailable$156$148.14 -2.4%Apr 9, 2026
Raymond JamesAnalyst unavailable$165$147.82 +3.2%Apr 8, 2026
UBSAnalyst unavailable$158$147.82 -1.2%Apr 8, 2026
Raymond JamesAnalyst unavailable$198$165.86 +23.9%Feb 1, 2026
Raymond JamesAnalyst unavailable$191$169.02 +19.5%Jan 28, 2026
Raymond JamesMichael Cyprys$187$163.01 +17.0%Dec 22, 2025
UBSMichael Brown$176$166.94 +10.1%Dec 11, 2025
Raymond JamesAnalyst unavailable$196$165.79 +22.6%Dec 10, 2025
Raymond JamesAnalyst unavailable$194$164.98 +21.3%Oct 23, 2025
Raymond JamesBrennan Hawken$182$166.04 +13.8%Oct 23, 2025
Raymond JamesAnalyst unavailable$181$166.04 +13.2%Oct 23, 2025
Raymond JamesDevin Ryan$190$162.06 +18.8%Oct 23, 2025
Raymond JamesDevin Ryan$185$165.15 +15.7%Oct 9, 2025
Raymond JamesAnalyst unavailable$178$167.64 +11.3%Oct 7, 2025
Raymond JamesAnalyst unavailable$173$165.9 +8.2%Oct 2, 2025
Raymond JamesAnalyst unavailable$184$168.6 +15.1%Oct 1, 2025
Raymond JamesDevin Ryan$180$159.31 +12.6%Jul 14, 2025
Raymond JamesCraig Siegenthaler$159$137.26 -0.5%Apr 24, 2025
Raymond JamesAnalyst unavailable$161$144.19 +0.7%Mar 4, 2025
Raymond JamesChristopher Allen$170$154.21 +6.3%Jan 10, 2025
Raymond JamesWilliam Kirk$150$149.05 -6.2%Oct 30, 2024
Raymond JamesMichael Cyprys$132$136.51 -17.4%Oct 17, 2024
Raymond JamesDevin Ryan$146$124.9 -8.7%Oct 9, 2024
Wells FargoChristopher Harris$138$115.95 -13.7%Sep 11, 2024
Raymond JamesDaniel Fannon$123$119.51 -23.1%Jul 8, 2024
Raymond JamesWilliam Kirk$130$125.36 -18.7%May 24, 2024
Raymond JamesBill Katz$126$123.39 -21.2%May 24, 2024
Seaport GlobalJim Mitchell$139$129.61 -13.1%Apr 4, 2024
Raymond JamesMark McLaughlin$145$128.43 -9.3%Apr 2, 2024
Raymond JamesMark McLaughlin$122$106.83 -23.7%Sep 11, 2023
UBSAnalyst unavailable$125$110.71 -21.8%Jan 9, 2023
Raymond JamesAnalyst unavailable$130.07$67.71 -18.6%Apr 29, 2022
Morgan StanleyManan Gosalia$128$98.45 -19.9%Mar 14, 2022
Show less

Track every rating change on RJF the moment it posts. Free to start.

Start free

Company context

Snapshot as of publication

Raymond James Financial, Inc. operates as a comprehensive financial services firm, extending a wide array of services to individuals, businesses, and governmental entities throughout the United States, Canada, and Europe. Its diverse operations are categorized into several key segments: Private Client Group, Capital Markets, Asset Management, Banking, and an "Other" category. The Private Client Group division equips clients with various investment solutions, personalized portfolio management, a selection of insurance and annuity products, and mutual funds. This segment also provides essential backing to third-party product partners, covering aspects like sales and marketing support, distribution, accounting, and general administrative assistance. Additionally, it facilitates margin loans and offers securities borrowing and lending services.…

Historical context

All RJF earnings

Financial Services peers this season

Latest reports in the same sector

Latest beats and misses

Who reports next

Get the RJF recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.

Sources

  1. Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
  2. FN2 earnings calendar · 2026-07-26T00:37:12.209961+00:00
  3. Polygon adjusted daily market bars · 2026-09-25T21:21:04.423614+00:00
  4. Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-09-25T21:21:04.420543+00:00

Methodology

Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.

Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.

Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.

By FN2 Research · Updated · As of 2026-09-25. For educational purposes only; not investment advice.